Curate Biosciences Competitors and Similar CompaniesClear all
Curate Biosciences's competitors and similar companies include Denali Therapeutics, Futura Genetics and Orchard Therapeutics.
 Curate Biosciences Curate Biosciences (formerly known as GPB Scientific) is a company involved in the processing of cells for gene and cell therapies. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. | |||
Founding Date | Founding Date 2002 | Founding Date 2015 | Founding Date 2014 | Founding Date 2015 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Carlsbad, US HQ Richmond, US | Locations South San Francisco, US HQ | Locations Tel Aviv-Yafo, IL HQ Coquitlam, CA | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US |
Employees | Employees 340% decrease | Employees 26146% increase | Employees 5 | Employees 166 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.8 b | Valuation ($) N/A | Valuation ($) 380.1 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $330.5m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) |
Net income | Net income N/A | Net income ($145.2m) (FY, 2023) | Net income N/A | Net income ($150.7m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 31.5m | Total funding raised $ 424.4m | Total funding raised N/A | Total funding raised $ 310.7m |
For sources of this data, please see the company profile
View Company Profiles
Denali Therapeutics
HQ
South San Francisco, US
Employees
261↑ 46% increase
Denali Therapeutics is a biotechnology company.
View company
Futura Genetics
HQ
Tel Aviv-Yafo, IL
Employees
5
Futura Genetics specializes in lifestyle and healthcare genetic testing.
View companyOrchard Therapeutics
HQ
London, GB
Employees
166
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
View company